Literature DB >> 8665464

Chlamydia pneumoniae (TWAR).

C C Kuo1, L A Jackson, L A Campbell, J T Grayston.   

Abstract

Chlamydia pneumoniae (TWAR) is a recently recognized third species of the genus Chlamydia that causes acute respiratory disease. It is distinct from the other two chlamydial species that infect humans, C. trachomatis and C. psittaci, in elementary body morphology and shares less than 10% of the DNA homology with those species. The organism has a global distribution, with infection most common among children between the ages of 5 and 14 years. In children, TWAR infection is usually mild or asymptomatic, but it may be more severe in adults. Pneumonia and bronchitis are the most common clinical manifestations of infection, and TWAR is responsible for approximately 10% of cases of pneumonia and 5% of cases of bronchitis in the United States. The microimmunofluorescence serologic assay is specific for TWAR and can distinguish between recent and past infections. The organism can be isolated in cell culture; however, PCR techniques have recently facilitated its detection in tissues and clinical specimens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8665464      PMCID: PMC172870          DOI: 10.1128/CMR.8.4.451

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  117 in total

1.  Recovery of Chlamydia pneumoniae, in six patients with otitis media with effusion.

Authors:  H Ogawa; K Hashiguchi; Y Kazuyama
Journal:  J Laryngol Otol       Date:  1992-06       Impact factor: 1.469

2.  Lumbosacral meningoradiculitis associated with Chlamydia pneumoniae infection.

Authors:  D Michel; J C Antoine; B Pozzetto; O G Gaudin; F Lucht
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-06       Impact factor: 10.154

3.  Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor.

Authors:  R P Verkooyen; M A Hazenberg; G H Van Haaren; J M Van Den Bosch; R J Snijder; H P Van Helden; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

4.  Chlamydia trachomatis-associated ectopic pregnancy: serologic and histologic correlates.

Authors:  R C Brunham; R Peeling; I Maclean; M L Kosseim; M Paraskevas
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

5.  Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract.

Authors:  K H Wong; S K Skelton; Y K Chan
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  Factors influencing the infectivity of Chlamydia pneumoniae elementary bodies on HL cells.

Authors:  J J Theunissen; B Y van Heijst; J H Wagenvoort; E Stolz; M F Michel
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

7.  Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease.

Authors:  D H Thom; J T Grayston; D S Siscovick; S P Wang; N S Weiss; J R Daling
Journal:  JAMA       Date:  1992-07-01       Impact factor: 56.272

8.  Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene.

Authors:  C A Gaydos; T C Quinn; J J Eiden
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

9.  In vitro activities of five quinolones against Chlamydia pneumoniae.

Authors:  M R Hammerschlag; C L Hyman; P M Roblin
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

10.  Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.

Authors:  M B Aldous; J T Grayston; S P Wang; H M Foy
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

View more
  199 in total

1.  Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens.

Authors:  P Apfalter; F Blasi; J Boman; C A Gaydos; M Kundi; M Maass; A Makristathis; A Meijer; R Nadrchal; K Persson; M L Rotter; C Y Tong; G Stanek; A M Hirschl
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  Chlamydia pneumoniae and atherosclerosis.

Authors:  J D Rutherford
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

3.  Chlamydial serology: comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens.

Authors:  S Bas; P Muzzin; B Ninet; J E Bornand; C Scieux; T L Vischer
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

4.  Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens.

Authors:  M Smieja; J B Mahony; C H Goldsmith; S Chong; A Petrich; M Chernesky
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

5.  Chlamydia pneumoniae in vitro and in vivo: a critical evaluation of in situ detection methods.

Authors:  A Meijer; P J Roholl; S K Gielis-Proper; Y F Meulenberg; J M Ossewaarde
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

6.  Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells.

Authors:  K Wolf; E Fischer; T Hackstadt
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

7.  Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

8.  Cell-mediated immune response during primary Chlamydia pneumoniae infection.

Authors:  S Halme; J Latvala; R Karttunen; I Palatsi; P Saikku; H M Surcel
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

9.  Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for [correction of factors is required for] major histocompatibility complex antigen expression.

Authors:  Peiyi Fan; Feng Dong; Yanqing Huang; Guangming Zhong
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

10.  Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae.

Authors:  Olga Tapia; Anatoly Slepenkin; Evgueni Sevrioukov; Kathi Hamor; Luis M de la Maza; Ellena M Peterson
Journal:  Clin Diagn Lab Immunol       Date:  2002-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.